Advertisement

Lifetime Prevalence of Major Depression and Its Effect on Treatment Outcome in Obese Type II Diabetic Patients

  1. Marsha D Marcus, PHD,
  2. Rena R Wing, PHD,
  3. John Guare, MA,
  4. Elaine H Blair, PHD and
  5. Abbas Jawad, MS
  1. Department of Psychiatry, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania
  1. Address Correspondence and Reprint Requests to Marsha D. Marcus, PHD, Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, PA 15213.

Abstract

Objective — To assess the lifetime prevalence of major depression (MD) and its relation to glycemic control among a group of non-insulin-dependent (type II) diabetic subjects seeking obesity treatment and to determine whether a history of MD affected response to treatment.

Research Design and Methods — Sixty-six obese subjects with type II diabetes (22 men, 44 women) completed the Inventory to Diagnose Depression-Lifetime Version before a 52-wk behavioral weight-control program. Weight, glycosylated hemoglobin, fasting blood glucose, and mood were assessed at pre-and posttreatment.

Results — Thirty-two percent of the subjects reported a history of MD. Neither a history of MD nor current depressive symptoms were associated with pretreatment glycemic control. However, a history of MD was related to treatment attrition (52.4 vs. 22.2%, P = 0.03). Subjects with and without a history of MD showed comparable improvements in weight, glycemic control, and mood.

Conclusions — A history of MD among type II diabetic patients seeking obesity treatment was not related to pretreatment glycemic control but was associated with higher rates of attrition from treatment. Individuals with a history of MD who completed the program did not differ from those with no history of MD in response to treatment.

  • Received February 13, 1991.
  • Accepted July 17, 1991.
| Table of Contents
Advertisement